Stay updated with breaking news from Andre Vlok. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phebra takes part ownership of Flexipharm Austrading through share purchase Builds on Phebra's Existing UK Distribution Agreement Strengthens Phebra's Presence in UK and Europe SYDNEY
Conflict is inevitable in politics, and it should not be avoided or sugar-coated. The conflicts that arise from the competition for resources and priorities should be seen by the wise politician as energies to be guided and used for the benefit of the public good, writes Andre Vlok.
Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations News provided by Share this article SYDNEY, May 13, 2021 /PRNewswire/ -- Australian pharmaceutical group Phebra (' Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract builds on the initial bioequivalence data from the first phase of the trial, published at EHA in June 2019 and reveals th...
SYDNEY, May 14, 2021 /PRNewswire/ — Australian pharmaceutical group Phebra (‘ Company‘) congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract builds on the initial bioequivalence data from the first phase of the trial, published at EHA in June 2019 and reveals the final results from the ALLG APML5 bioavailability study undertaken by the ALLG at hospitals across Australia in 31 patients with previously untreated APL. The aim of the APML5 study, was to c...